The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Brodilaten 5.0 mg/2.5 ml Nebuliser solution

Noridem Enterprises LimitedPA1122/024/003

Main Information

Trade NameBrodilaten 5.0 mg/2.5 ml Nebuliser solution
Dosage FormNebuliser solution
Licence HolderNoridem Enterprises Limited
Licence NumberPA1122/024/003

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol


License statusAuthorised
Licence Issued13/09/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0078-139-052
Interchangeable List DocumentPDF of Interchangeable List
« Back